Screener
FINX vs GNOM
Global X FinTech ETF vs Global X Genomics & Biotechnology ETF
Key differences
- GNOM costs 0.18% less per year.
- FINX is significantly larger than GNOM — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, FINX has delivered higher annualized returns.
Side-by-side comparison
| FINX | GNOM | |
|---|---|---|
| Annual cost (TER) | 0.68% | 0.50% |
| Fund size (AUM) | $191M | $51M |
| Since | 2016 | 2019 |
| Dividend yield | 0.68% | 1.38% |
| Asset class | equity | equity |
| Region | — | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | -16.6% | +53.6% |
| CAGR 3Y | +7.0% | -2.6% |
| CAGR 5Y | -8.8% | -10.5% |
| Sharpe 3Y | 0.25 | -0.06 |
| Volatility 1Y | 28.79% | 26.15% |
| Max drawdown | -63.53% | -75.00% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to FINX and GNOM
Explore further